With the Anglonordic Life Science Conference last week, BioEquity next week, ASGCT Annual meeting and LSX Nordic Congress around the corner, it is a good time to practice your pitching. Funds are open and now is the time to foster those new and old connections. Read on to discover what has happened this week and […]
Investment firms Jeito Capital raised a record $1.2 billion for Jeito II Fund to support clinical stage biopharma companies developing breakthrough therapies for diseases with high unmet medical needs Kurma Partners raised €215 million for Biofund IV to support the discovery and development of disruptive therapeutic solutions for severe or incurable diseases British Business Bank made a £100 million cornerstone commitment to Apposite Healthcare Growth Fund I to support innovative companies across medical products, diagnostics, life science tools, digital health and […]
Biotechs are becoming increasingly cautious about what they publish in scientific journals. The growing worry is that other companies, often based in China, will take the freshly published information and run with it – and go on to develop a target or very early stage drug much faster than the originator. This was a subject raised last week on a panel at the Anglonordic Life Science Conference in London, by Dr Adi Hoess, CEO […]
A profoundly positive response from Anglonordic attendees with hands shaken, conversations started and potential deals in the works. The main takeaway was the benefit of it being a ‘boutique’ event, meaning everyone could make the most of the 1:1 partnering, pitch presentations, and networking breaks. Keep reading to hear more about what’s been happening this […]
Drum roll… In Vivo’s 2026 Rising Leaders were announced this week and included not one, not two, but five Optimum clients. A huge congratulations to Colleen Acosta of Freya Biosciences, Diana Čekatauskaitė of Lonza’s Synaffix, Reuben Dawkins of Link Biologics, Michelle Morrow of Nucleome Therapeutics, and Javier Nunez-Vicandi of Sofinnova Partners. This list recognises not […]
